Surgery Viable for Advanced Prostate Cancer, Study
TUESDAY, May 17 (HealthDay News) -- Surgery to remove the
prostate gland (radical prostatectomy) led to a 20-year survival
rate for 80 percent of patients with advanced prostate cancer, a
new study finds.
The study included patients with cancer that had spread beyond
the prostate, known as cT3 prostate cancer, and underwent radical
prostatectomy between 1987 and 1997.
The 80 percent survival rate in these patients compares to a 90
percent survival rate at 20 years for patients with cancer confined
to the prostate (cT2 prostate cancer), the Mayo Clinic researchers
Previously, patients with cT3 prostate cancer were offered
radiation or hormone treatment, but not radical prostatectomy, the
study authors noted in a Mayo news release.
"We are doing a much better job of identifying and expanding candidates for surgery, which results in better, longer outcomes for so many of our patients," Dr. R. Jeffrey Karnes, of the department of urology, said in the news release.
The study was slated for presentation May 15 at the annual
meeting of the American Urological Association, in Washington, D.C.
Research presented at meetings is considered preliminary until it
is published in a peer-reviewed journal.
The American Cancer Society has more about
Copyright © 2011
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.